Corrine Renne, DPM
Foot Surgery · Franklin Square, NYNPI 1740456169
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.9%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 21.1%. Reporting peaked in 2022 at $7,122 and has fallen 90.2% since, to $697 in 2025. Among foot surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 142 payments — averaging $138.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medimetriks Pharmaceuticals, Inc.$4K
- Zimmer Biomet$2K
- Abbott$2K
- Anika Therapeutics, Inc.$1K
- Arthrosurface Incorporated$1K
- Smith+Nephew$1K
- plus $8K from 32 others
What the payments were for
- Consulting fees$4,22421%
- Travel & lodging$5,05126%
- Food & beverage$10,43553%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medimetriks Pharmaceuticals, Inc. | 3 | $4,149 |
| Zimmer Biomet | 20 | $2,367 |
| Abbott | 12 | $1,507 |
| Anika Therapeutics, Inc. | 2 | $1,298 |
| Arthrosurface Incorporated | 6 | $1,142 |
| Smith+Nephew | 7 | $1,119 |
| Treace Medical Concepts, Inc. | 6 | $1,082 |
| Medtronic(2 entities) | 12 | $936 |
| Nevro Corp. | 10 | $765 |
| Baxter Healthcare | 7 | $637 |
| Bolton Medical Inc | 3 | $443 |
| Advanced Oxygen Therapy Inc. | 7 | $436 |
| Organogenesis Inc. | 3 | $356 |
| Orthofix Medical, Inc. | 6 | $315 |
| Amgen(2 entities) | 4 | $302 |
| Celularity Inc. | 1 | $267 |
| Angiodynamics, Inc. | 2 | $252 |
| Bone Support Inc. | 2 | $249 |
| Acumed LLC | 2 | $227 |
| Bioventus LLC | 3 | $202 |
| Access Pro Medical, LLC | 2 | $198 |
| Paratek Pharmaceuticals, Inc. | 3 | $173 |
| Stryker | 1 | $172 |
| AbbVie | 1 | $125 |
| Osiris Therapeutics Inc. | 1 | $124 |
| Stability Biologics, LLC | 1 | $124 |
| KCI USA, Inc. | 1 | $121 |
| GRT US Holding, Inc. | 1 | $121 |
| Triad Life Sciences Inc. | 1 | $109 |
| Averitas Pharma Inc. | 3 | $90 |
| DJO, LLC | 1 | $67 |
| Kerecis Limited | 1 | $47 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $46 |
| Glenmark Therapeutics Inc. | 1 | $36 |
| Melinta Therapeutics, LLC | 1 | $29 |
| Avanos Medical | 1 | $26 |
| Convatec Inc. | 1 | $25 |
| Sebela Pharmaceuticals Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Neo-Synalar$4,100
- Lapiplasty System$969
- HemiCAP MTP Resurfacing$957
- OVO$790
- Supera peripheral stent system$765
- Versajet$690
- InCore Lapidus$680
- AccuFill$588
- FnA Products$508
- Senza$472
- SUPERA$443
- Relay Plus$443
- HawkOne$365
- PuraPly$356
- Stratum Foot Plating System$273
- KRYSTEXXA$271
- Biovance$267
- Interfyl$267
- UltraMist$267
- COLLAGENASE SANTYL$255
How this compares
$19,709 in reported general payments places this provider in the 95th percentile of 294 foot surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neo-SynalarNeomycin Sulfate/Fluocinolone | 48 | $45,097 |
| JubliaEfinaconazole | 31 | $33,600 |
| Ketoconazole | 66 | $21,365 |
| Clindamycin Phosphate | 75 | $5,502 |
| Tavaborole | 19 | $5,251 |
| ClindacinClindamycin Phosphate | 13 | $4,697 |
| Fluocinonide | 18 | $1,059 |
| Clotrimazole | 11 | $552 |
| Ciclopirox | 14 | $237 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Medimetriks Pharmaceuticals, Inc.Neo-Synalar | $4,149 | $45,09748 claims |
| Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia | $46 | $33,60031 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 294 foot surgery providers in New York.
Other foot surgery in Franklin Square
- Ronald GubermanRidgewood$337K
- John JackaloneBethpage$66K
- David WongBronx$45K
- Berdj StepanianWhite Plains$26K
- Lawrence SantiBrooklyn$25K
- David GitlinBayside$24K
- Rick DelmonteNew York$21K
- Charles MorelliMamaroneck$18K
- Evan BrethBrooklyn$17K
- Wayne AxmanAstoria$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.